PTC
PCVX icon

Private Trust Company’s Vaxcyte PCVX Stock Holding History

Private Trust Company’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16K Hold
20
– – ﹤0.01% 2578
2026
Q1 		$1.16K Hold
20
– – ﹤0.01% 2458
2025
Q4 		$923 Hold
20
– – ﹤0.01% 2433
2025
Q3 		$720 Buy
+20
New +$663 ﹤0.01% 2465
2025
Q2 		– Sell
-31
Closed -$1.17K – 2549
2025
Q1 		$1.17K Buy
+31
New +$2.48K ﹤0.01% 2342
2024
Q4 		– Sell
-69
Closed -$7.88K – 2389
2024
Q3 		$7.88K Buy
+69
New +$6.22K ﹤0.01% 1807

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Private Trust Company's PCVX Position: Q2 2026 in Review

Private Trust Company held its Vaxcyte (PCVX) position steady in Q2 2026 at 20 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

Private Trust Company first reported a position in PCVX in Q3 2024 and has held it in 6 quarters since. The position peaked at $7.88K in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Private Trust Company held 20 shares of Vaxcyte worth $1.16K as of Q2 2026.
  • Private Trust Company left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2578 holding.
  • Private Trust Company first reported a position in Vaxcyte in Q3 2024 and has held it in 6 quarters since.
  • Private Trust Company's Vaxcyte position peaked at $7.88K in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.